-
801
Immunomodulatory insights of monoterpene glycosides in endometriosis: immune infiltration and target pathways analysis
Published 2025-01-01Subjects: Get full text
Article -
802
-
803
Nanotechnology and nanosensors in personalized healthcare: A comprehensive review
Published 2025-02-01Subjects: Get full text
Article -
804
Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
805
Drugs as a cause of perforating dermatoses – a literature review
Published 2024-11-01Subjects: Get full text
Article -
806
Exploring Potential Complement Modulation Strategies for Ischemia–Reperfusion Injury in Kidney Transplantation
Published 2025-01-01Subjects: Get full text
Article -
807
An integrative analysis reveals cancer risk associated with artificial sweeteners
Published 2025-01-01Subjects: Get full text
Article -
808
Doctoral Studies in the Context of Global Trends: Problems and Key Factors of Development
Published 2022-05-01Subjects: Get full text
Article -
809
-
810
ENFLASYON HEDEFLEME POLİTİKASI, UYGULAMALAR VE TÜRKİYE’DE UYGULANABİLİRLİĞİ
Published 2005-12-01Subjects: Get full text
Article -
811
Current status of cytokine-induced killer cells and combination regimens in breast cancer
Published 2025-02-01Subjects: Get full text
Article -
812
PARA POLİTİKASI STRATEJİSİ OLARAK ENFLASYON HEDEFLEMESİ REJİMİ: TEORİ, POLİTİKA VE TÜRKİYE ÜZERİNE BİR DEĞERLENDİRME
Published 2009-06-01Subjects: Get full text
Article -
813
Case report: Tongue metastasis as an initial sign of clear cell renal cell carcinoma and its prognosis
Published 2025-01-01Subjects: Get full text
Article -
814
Extracellular vesicle surface engineering with integrins (ITGAL & ITGB2) to specifically target ICAM-1-expressing endothelial cells
Published 2025-01-01Subjects: Get full text
Article -
815
TÜRKİYE’DE ENFLASYON VE ENFLASYON HEDEFLEMESİ UYGULAMASININ DEĞERLENDİRİLMESİ
Published 2011-12-01Subjects: Get full text
Article -
816
Combination of Anti-programmed Cell Death Protein 1 and Antiangiogenesis Displaying a Response Disparity between Pulmonary and Nonpulmonary Metastases
Published 2023-10-01Subjects: “…vascular endothelial growth factor-targeted therapy…”
Get full text
Article -
817
Neratinib and the Role of Anti‐HER2 Therapy in Salivary Duct Carcinoma
Published 2025-01-01Subjects: Get full text
Article -
818
Efficacy and safety of selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors in FGFR-altered urothelial carcinoma
Published 2025-01-01Subjects: Get full text
Article -
819
Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression
Published 2025-01-01Subjects: Get full text
Article -
820
Tumor Site‐Specific In Vivo Theranostics Enabled by Microenvironment‐Dependent Chemical Transformation and Self‐Amplifying Effect
Published 2025-01-01Subjects: Get full text
Article